1–4 of 4 results for Edward H. Wood
Safety Profiles of Combined Anticomplement and Anti-VEGF Intravitreal Therapies for Age-Related MacularDegeneration From Real-World Data
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2025
The incidence and timing of treatment-requiring retinopathy of prematurity (ROP) in nanopremature and micropremature infants in the United States
2023
Subretinal Delivery of Investigational ABBV-RGX-314 for Neovascular Age-Related Macular Degeneration: A Phase II Pharmacodynamic Study
2024
Laser Photocoagulation for Type 2 Retinopathy of Prematurity (ROP) or Less: When and Why?
2020